Evidence map›Paper›PMID 33194811›Full record

ArticleFrontiers in cellular and infection microbiology2020

The Synergistic Effect of Mud Crab Antimicrobial Peptides Sphistin and Sph

Jie Liu, Fangyi Chen, Xiaofei Wang, Hui Peng, Hua Zhang, Ke-Jian Wang

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Discovery of a Novel Antimicrobial Peptide fromAntibiotics (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Recombinase-aided amplification assay for rapid detection of imipenem-resistantFrontiers in cellular and infection microbiology · 2024
    Article
  9. Article
  10. Review
  11. Anti-Frontiers in microbiology · 2023
    Review
  12. Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV-Infected Patients.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Review
  13. Review
  14. Article
  15. A Novel Antimicrobial Peptide SpampcinInternational journal of molecular sciences · 2022
    Article
  16. Article
  17. Review
  18. Anti-Iranian journal of basic medical sciences · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jie LiuState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen, China.
Fangyi ChenState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen, China.
Xiaofei WangState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen, China.
Hui PengState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen, China.
Hua ZhangState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen, China.
Ke-Jian WangState Key Laboratory of Marine Environmental Science, College of Ocean & Earth Sciences, Xiamen University, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Overuse or abuse of antibiotics has undoubtedly accelerated the increasing prevalence of global antibiotic resistance crisis, and thus, people have been trying to explore approaches to decrease dosage of antibiotics or find new antibacterial agents for many years. Antimicrobial peptides (AMPs) are the ideal candidates that could kill pathogens and multidrug-resistant bacteria either alone or in combination with conventional antibiotics. In the study, the antimicrobial efficacy of mud crab

Indexed as

AzithromycinBrachyuraAnimalsAnti-Bacterial AgentsMicrobial Sensitivity TestsPore Forming Cytotoxic ProteinsPseudomonas aeruginosaRifampinAnti-Bacterial AgentsAzithromycinPore Forming Cytotoxic ProteinsRifampinantimicrobial peptidesazithromycinPseudomonas aeruginosarifampicinSph12−38Sphistinsynergistic efficacy

Identifiers

PMID33194811
PMCPMC7645104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.